549
Views
40
CrossRef citations to date
0
Altmetric
ORIGINAL INVESTIGATION

The influence of concomitant antidepressant medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy

, , , , , , , , , & show all
Pages 82-90 | Received 03 Mar 2005, Published online: 12 Jul 2009

References

  • Abrams R. Recent clinical studies of ECT. Semin Psychiatry 1972; 4: 3–12
  • Abrams R. Stimulus titration and ECT dosing. J. ECT. 2002; 18: 3–9
  • Abrams R, Swartz CM, Vedak C. Antidepressant effects of high-dose right unilateral electroconvulsive therapy. Arch Gen Psychiatry 1991; 48: 746–748
  • Agelink MM, Zeit T, Klieser E. Prolonged bradycardia complicates antidepressive treatment with venlafaxine and ECT. Br J Psychiatry 1998; 173: 441
  • Baghai, TC, Moller, H-J, Rupprecht, R. 2006. Recent progress in pharmacological and non-pharmacological treatment options of major depression. Curr Pharm Design, 12:503–515.
  • Bernardo M, Navarro V, Salva J, Arrufat FJ, Baeza I. Seizure activity and safety in combined treatment with venlafaxine and ECT: A pilot study. J ECT 2000; 16: 38–42
  • Coffey CE, Lucke J, Weiner RD, Krystal AD, Aque M. Seizure threshold in electroconvulsive therapy: I. Initial seizure threshold. Biol. Psychiatry 1995; 37: 713–720
  • Conway CR, Nelson LA. The combined use of bupropion, lithium, and venlafaxine during ECT: A case of prolonged seizure activity. J ECT 2001; 17: 216–218
  • Curran S. Effect of paroxetine on seizure length during electroconvulsive therapy. Acta Psychiatr Scand 1995; 92: 239–240
  • D'Elia G. Unilateral electroconvulsive therapy. Acta Psychiatr Scand 1970; Suppl 215: 1–98
  • D'Elia G, Raotma H. Is unilateral ECT less effective than bilateral ECT?. Br J Psychiatry 1975; 126: 83–89
  • ECT Review Group. Efficacy and safety of electroconvulsive therapy in depressive disorders: A systematic review and meta-analysis. Lancet 2003; 361: 799–808
  • Folkerts HW, Michael N, Tolle R, Schonauer K, Mucke S, Schulze-Monking H. Electroconvulsive therapy vs. paroxetine in treatment-resistant depression – a randomized study. Acta Psychiatr Scand 1997; 96: 334–342
  • Frey R, Heiden A, Scharfetter J, Schreinzer D, Blasbichler T, Tauscher J, Felleiter P, Kasper S. Inverse relation between stimulus intensity and seizure duration: Implications for ECT procedure. J ECT 2001; 17: 102–108
  • Gonzalez-Pinto A, Gutierrez M, Gonzalez N, Elizagarate E, Perez De Heredia JL, Mico JA. Efficacy and safety of venlafaxine-ECT combination in treatment-resistant depression. J Neuropsychiatry Clin Neurosci 2002; 14: 206–209
  • Greenblatt, M, Grosser, GH, Wechsler, HA. 1964. Differential response of hospitalized depressed patients in somatic therapy. Am J Psychiatry. 935–943.
  • Gutierrez-Esteinou R, Pope HG, Jr. Does fluoxetine prolong electrically induced seizures?. Convuls Ther 1989; 5: 344–348
  • Hirschfeld RM. Efficacy of SSRIs and newer antidepressants in severe depression: comparison with TCAs. J Clin Psychiatry 1999; 60: 326–335
  • ICD-10 Task Force. Report of the ICD-10 Task Force. American Medical Record Association. J Am Med Rec Assoc 1987; 58: 51–56
  • Janicak PG, Davis JM, Gibbons RD, Ericksen S, Chang S, Gallagher P. Efficacy of ECT: A meta-analysis. Am J Psychiatry 1985; 142: 297–302
  • Jha A, Tomar R. Interaction between ECT and venlafaxine. Int J Geriatr Psychiatry 2002; 17: 979–980
  • Lauritzen L, Odgaard K, Clemmesen L, Lunde M, Ohrstrom J, Black C, Bech P. Relapse prevention by means of paroxetine in ECT-treated patients with major depression: A comparison with imipramine and placebo in medium-term continuation therapy. Acta Psychiatr Scand 1996; 94: 241–251
  • Mayur PM, Gangadhar BN, Subbakrishna DK, Janakiramaiah N. Discontinuation of antidepressant drugs during electroconvulsive therapy: A controlled study. J Affect Disord 2000; 58: 37–41
  • McCall WV, Reboussin DM, Weiner RD, Sackeim HA. Titrated moderately suprathreshold vs fixed high-dose right unilateral electroconvulsive therapy: acute antidepressant and cognitive effects. Arch Gen Psychiatry 2000; 57: 438–444
  • National Institute of Mental Health. 1976. 028 CGI. Clinical global impressions. In:. W Guy, Bonato, RR, editors. Manual for the EDCEU Assessment Battery, 2. Rev. Chevy Chase, MD: National Institute of Mental Health. pp, 12-1–12-6.
  • Nelson JP, Benjamin L. Efficacy and safety of combined ect and tricyclic antidepressant drugs in the treatment of depressed geriatric patients. Convuls Ther 1989; 5: 321–329
  • Nobler MS, Sackeim HA, Solomou M, Luber B, Devanand DP, Prudic J. EEG manifestations during ECT: Effects of electrode placement and stimulus intensity. Biol. Psychiatry 1993; 34: 321–330
  • Parker G, Mitchell P, Wilhelm K, Menkes D, Snowdon J, Schweitzer I, Grounds D, Skerritt P, Roy K, Hadzi-Pavlovic D. Are the newer antidepressant drugs as effective as established physical treatments? Results from an Australasian clinical panel review. Aust NZ J Psychiatry 1999; 33: 874–881
  • Perera TD, Luber B, Nobler MS, Prudic J, Anderson C, Sackeim HA. Seizure expression during electroconvulsive therapy: Relationships with clinical outcome and cognitive side effects. Neuropsychopharmacology 2004; 29: 813–825
  • Prudic J, Sackeim HA, Devanand DP. Medication resistance and clinical response to electroconvulsive therapy. Psychiatry Res 1990; 31: 287–296
  • Prudic J, Haskett RF, Mulsant B, Malone KM, Pettinati HM, Stephens S, Greenberg R, Rifas SL, Sackeim HA. Resistance to antidepressant medications and short-term clinical response to ECT. Am J Psychiatry 1996; 153: 985–992
  • Sackeim HA, Decina P, Kanzler M, Kerr B, Malitz S. Effects of electrode placement on the efficacy of titrated, low-dose ECT. Am J Psychiatry 1987; 144: 1449–1455
  • Sackeim HA, Prudic J, Devanand DP, Kiersky JE, Fitzsimons L, Moody BJ, McElhiney MC, Coleman EA, Settembrino JM. Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. New Engl J Med 1993; 328: 839–846
  • Sackeim HA, Prudic J, Devanand DP, Nobler MS, Lisanby SH, Peyser S, Fitzsimons L, Moody BJ, Clark J. A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Arch Gen Psychiatry 2000; 57: 425–434
  • Sartorius N. The ICD-10 and depression. Acta Psychiatr Scand Suppl 1983; 310: 103–105
  • Suppes T, Webb A, Carmody T, Gordon E, Gutierrez-Esteinou R, Hudson JI, Pope HG, Jr. Is postictal electrical silence a predictor of response to electroconvulsive therapy?. J Affect Disord 1996; 41: 55–58
  • Swartz CM, Larson G. Generalization of the effects of unilateral and bilateral ECT. Am J Psychiatry 1986; 143: 1040–1041
  • Swartz CM, Abrams R, Rasmussen K, Pavel J, Zorumski CF, Srinivasaraghavan J. Computer automated versus visually determined electroencephalographic and electromyographic seizure duration. Convuls Ther 1994; 10: 165–170
  • Thase ME, Friedman ES, Howland RH. Venlafaxine and treatment-resistant depression. Depress Anxiety 2000; 12(Suppl 1)55–62
  • Weiner RD, Weaver LA, Jr, Sackeim HA. Reporting of Technical Parameters in ECT Publications: Recommendations for Authors. Convuls Ther 1988; 4: 88–91
  • Weiner RD, Coffey CE, Krystal AD. The monitoring and management of electrically induced seizures. Psychiatr Clin North Am 1991; 14: 845–869
  • World Health Organization. 1992. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines). Geneva: World Health Organization.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.